STUDY ON THE ASSOCIATION OF NLR, SII, AND RDW WITH mRS IN ACUTE ISCHEMIC STROKE TREATED WITH INTRAVENOUS THROMBOLYSIS
Main Article Content
Abstract
Objectives: To investigate the association of NLR (neutrophil-to-lymphocyte ratio), SII (systemic immune-inflammation index), and RDW (red cell distribution width) according to the modified Rankin scale (mRS) in predicting early neurological functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis. Methods: A cross-sectional descriptive study with pre- and post-discharge follow-up was conducted on 105 patients with acute ischemic stroke who received intravenous thrombolysis at Military Hospital 103 from January 2025 to April 2026. Results: Patients with poor functional outcomes (mRS 3-6) had higher median NLR and SII values than those with good outcomes (mRS 0-2), at 3.29 vs. 2.35 and 815.59 vs. 513.00, respectively (p = 0.005). Receiver operating characteristic (ROC) analysis showed that NLR and SII predicted poor outcome with AUC values of 0.666 (cut-off: 1.89; p = 0.003) and 0.665 (cut-off: 575.1; p = 0.004), respectively. Univariate logistic regression demonstrated an increased risk of poor outcomes in patients with NLR ≥ 1.89 (OR = 5.351), SII ≥ 575.1 (OR = 4.222) and higher admission NIHSS score (OR = 1.200). In multivariate analysis, only admission NIHSS score remained an independent predictor of poor functional outcome (mRS 3-6) (OR = 1.172; p = 0.002). Conclusion: Elevated NLR and SII were associated with an increased risk of poor functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis. However, these indices were not independent prognostic factors and should be evaluated in combination with admission NIHSS.
Keywords
Acute ischemic stroke, Modified Rankin scale (mRS), Neutrophil-to-lymphocyte ratio (NLR), Systemic immune-inflammation index (SII), Red cell distribution width (RDW)
Article Details
References
2. Bộ Y tế. Hướng dẫn chẩn đoán và xử trí đột quỵ não. Hà Nội. 2024.
3. Satumanatpan N, Tonpho W, Thiraratananukulchai N, et al. Factors associated with unfavorable functional outcomes after intravenous thrombolysis in patients with acute ischemic stroke. Int J Gen Med. 2022;15:3363-73.
4. Chamorro Á, Meisel A, Planas AM, et al. The immunology of acute stroke. Nature Reviews Neurology. 2012;8(7):401-10.
5. Zhou Y, Yang Q, Zhou Z, et al. Systemic immune-inflammation index is associated with clinical outcome of acute ischemic stroke patients after intravenous thrombolysis treatment. PLoS One. 2025;20(3):e0319920.
6. Trần Bùi Bình Chi và Hoàng Khánh. Tỷ bạch cầu đa nhân/bạch cầu lympho máu trong tiên lượng bệnh nhân nhồi máu não cấp. Tạp chí Thần kinh học Việt Nam. 2024;3(28):4-12.
7. Phạm Phúc Hải, Nguyễn Văn Hướng, Nguyễn Ngọc Hòa và CS. Kết quả điều trị tiêu sợi huyết bằng alteplase và các yếu tố tiên lượng ở bệnh nhân cao tuổi nhồi máu não cấp tại Bệnh viện Hữu nghị Đa khoa Nghệ An. Tạp chí Y học Việt Nam. 2025;554(2):41-5.
8. Jayaraj RL, Azimullah S, Beiram R, et al. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):1-24.
9. Turner RJ, Sharp FR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci. 2016;10:1-13.